NCT06366412View on ClinicalTrials.gov

Dexmedetomidine on Postoperative Cognitive Dysfunction and Serum Tau-217 Protein.

PHASE4RecruitingINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

April 30, 2024

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2026

Conditions
Cognitive Impairment
Interventions
DRUG

Dexmedetomidine Hydrochloride

dexmedetomidine effect in preventing postoperative cognitive dysfunction on elderly patients undergoing major surgery guided with serum Tau-217 protein.

OTHER

normal saline

normal saline will be administrated in placebo group

Trial Locations (1)

61111

RECRUITING

Arwa Essam, Minya

All Listed Sponsors
lead

Minia University Hospital

OTHER